MedPath

Breakfast Intervention Study

Conditions
Risk factors for cardiovascular disease such as hypertension and hypercholesterolemia in subjects with at least one clinical feature of the metabolic syndrome.
Cardiovascular - Other cardiovascular diseases
Registration Number
ACTRN12607000158460
Lead Sponsor
niversity of Western Australia, School of Medicine and Pharmacology.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
33
Inclusion Criteria

With at least one clinical feature of the metabolic syndrome as defined by the American Heart Association.

Exclusion Criteria

1.Use of pure vitamin E supplements. 2.Gastrointestinal disorders. 3.Used antibiotics 4 weeks prior to the study. 4.Alcohol intake >40g/day men 30g/day women. 5.Pre and perimenopausal women. 6.Smoking. 7.Recent coronary/cerebrovascular event <6months. Evidence of renal impairment. 8.Body Mass Index >35. 9.Use of lipid or hypertensive medications. 10. Diabetes requiring insulin. 11. Episodic use of non-steroidal anti-inflammatory medication. 12. History of heart failure

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Blood cholesterol levels.[Measured at baseline (at the beginning of the study and also at the end of week 9, i.e. after the wash out period) and immediately following each of the food bar interventions (i.e. at the end of weeks 5 and 14)];2. Blood pressure (ambulatory blood pressure monitoring).[Measured at baseline (at the beginning of the study and also at the end of week 9, i.e. after the wash out period) and immediately following each of the food bar interventions (i.e. at the end of weeks 5 and 14)];3.Serum vitamin E and mammalian lignan levels.[Measured at baseline (at the beginning of the study and also at the end of week 9, i.e. after the wash out period) and immediately following each of the food bar interventions (i.e. at the end of weeks 5 and 14)];4.Urinary vitamin E metabolite levels.[Measured at baseline (at the beginning of the study and also at the end of week 9, i.e. after the wash out period) and immediately following each of the food bar interventions (i.e. at the end of weeks 5 and 14)]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath